SEI Investments’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

SEI Investments’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-22,234	Closed	-$1.12M	–	2571
2020 Q3	$1.12M	Sell	22,234 -166	-0.7%	-$7.46K	﹤0.01%	1552
2020 Q2	$1.07M	Sell	22,400 -7,140	-24%	-$332K	﹤0.01%	1534
2020 Q1	$1.45M	Buy	29,540 +1,239	+4%	+$63.1K	0.01%	1289
2019 Q4	$1.62M	Buy	+28,301	New	+$1.4M	﹤0.01%	1434
2019 Q3	–	Sell	-14,609	Closed	-$454K	–	2451
2019 Q2	$454K	Buy	+14,609	New	+$396K	﹤0.01%	1927

Other funds holding EIDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

SEI Investments's EIDX Position: Q4 2020 in Review

SEI Investments sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q4 2020, closing a stake of 22,234 shares — an estimated $1.12M sold.

SEI Investments first reported a position in EIDX in Q2 2019 and held it in 5 quarters. The position peaked at $1.62M in Q4 2019. 121 funds tracked by Wall St. Rank hold EIDX as of Q4 2020.

SEI Investments reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
SEI Investments sold 22,234 Eidos Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $1.12M.
SEI Investments first reported a position in Eidos Therapeutics, Inc. Common Stock in Q2 2019 and held it in 5 quarters.
SEI Investments's Eidos Therapeutics, Inc. Common Stock position peaked at $1.62M in Q4 2019.
121 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q4 2020.

Based on SEI Investments's 13F filing for Q4 2020, filed 8 Feb 2021.